Clinical characteristics of ovarian cancer classified by brca1 brca2 and rad51c status

HIGHLIGHTS

• who: SUBJECT, AREAS and OVARIAN, CANCER from the Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota, Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, Department of Oncology, University of Cambridge, Cambridge, United Kingdom, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles and Jonsson Comprehensive Cancer Center, Los Angeles, California, Department of Translational . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.